Predict your next investment

Other

See what CB Insights has to offer

Investments

2

Portfolio Exits

1

About Aixiang Capital

Aixiang Capital (艾想资本) is based in China.

Aixiang Capital Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Aixiang Capital Investments

2 Investments

Aixiang Capital has made 2 investments. Their latest investment was in Health Cross as part of their Series A - II on August 8, 2018.

CBI Logo

Aixiang Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/8/2018

Series A - II

Health Cross

$7.31M

Yes

2

7/1/2015

Seed

Subscribe to see more

Subscribe to see more

10

Date

8/8/2018

7/1/2015

Round

Series A - II

Seed

Company

Health Cross

Subscribe to see more

Amount

$7.31M

New?

Yes

Subscribe to see more

Co-Investors

Sources

2

10

Aixiang Capital Portfolio Exits

1 Portfolio Exit

Aixiang Capital has 1 portfolio exit. Their latest portfolio exit was Woo Space on March 09, 2018.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/9/2018

Merger

$99M

8

Date

3/9/2018

Exit

Merger

Companies

Valuation

$99M

Acquirer

Sources

8

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.